Partner Fund Management, managed by Christopher Medlock James, has a net portfolio value of $5 billion according to their recent SEC 13F filing. Partner Fund Management has its largest share of investments in Allergan, Inc. (NYSE:AGN), Rite Aid Corporation (NYSE:RAD), and Vulcan Materials Company (NYSE:VMC), according to their filing. (You can check complete list of Partner Fund Management holdings here).
Allergan, Inc. (NYSE:AGN) is the top investment of Partner Fund Management with investments worth $275 million and 1,628,870 shares. Allergan, Inc. (NYSE:AGN) reported $1.37 diluted EPS for the second quarter 2014 as compared to $1.17 during the same period. The company improved its net product sales by 15.9% to $1.82 billion in the quarter. Some of the primary investors in Allergan, Inc (NYSE:AGN) include Pershing Square ($4.88 billion), Paulson & Co ($947 million), and Pentwater Capital Management ($662 million).
Rite Aid Corporation (NYSE:RAD) comes second in terms of investment in Partner Fund Management’s portfolio with investments of $255 million and 35,696,687 shares. Rite Aid Corporation (NYSE:RAD) announced net income of $41.4 million for its latest quarter with $6.5 billion in revenue. Partner Fund management is the largest investor in the company followed by Viking Global ($96 million) and Millennium Management ($75 million).
As per the 13F filing of Partner Fund Management, Vulcan Materials Company (NYSE:VMC) is the third major investment with $229 million invested in the company and the fund owns 3,598,626 shares of Vulcan Materials Company (NYSE:VMC). The company declared an increase of $60 million in net sales with aggregate segment revenues of $596 million. First Eagle Investment Management is the largest investor in Vulcan Materials Company (NYSE:VMC) with $304 million invested in the company followed by Partner Fund Management and Citadel Investment Group ($85 million).
This article has been written by Prakash Pandey.
Related Articles:
